Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Induced Pluripotent Stem Cells | 25 | 2023 | 1736 | 3.750 |
Why?
|
Histone Deacetylase Inhibitors | 27 | 2019 | 789 | 3.130 |
Why?
|
Histone Deacetylases | 22 | 2021 | 728 | 3.100 |
Why?
|
Tauopathies | 8 | 2023 | 307 | 2.830 |
Why?
|
Neurons | 43 | 2022 | 9338 | 2.570 |
Why?
|
Neural Stem Cells | 14 | 2022 | 851 | 2.290 |
Why?
|
tau Proteins | 13 | 2023 | 1868 | 2.230 |
Why?
|
Neuronal Plasticity | 11 | 2018 | 1422 | 1.690 |
Why?
|
Frontotemporal Dementia | 7 | 2020 | 248 | 1.560 |
Why?
|
Drug Discovery | 11 | 2019 | 1058 | 1.430 |
Why?
|
Central Nervous System Diseases | 3 | 2019 | 518 | 1.340 |
Why?
|
Hydroxamic Acids | 10 | 2019 | 494 | 1.170 |
Why?
|
Fragile X Mental Retardation Protein | 5 | 2019 | 117 | 1.100 |
Why?
|
Bipolar Disorder | 10 | 2022 | 5027 | 1.070 |
Why?
|
Drug Evaluation, Preclinical | 10 | 2019 | 1375 | 1.020 |
Why?
|
Models, Biological | 11 | 2021 | 9583 | 0.980 |
Why?
|
Epigenesis, Genetic | 11 | 2018 | 3647 | 0.950 |
Why?
|
Nerve Tissue Proteins | 15 | 2021 | 4462 | 0.940 |
Why?
|
Histone Demethylases | 2 | 2016 | 321 | 0.930 |
Why?
|
Hydrazines | 2 | 2016 | 226 | 0.850 |
Why?
|
Histone Deacetylase 1 | 10 | 2021 | 137 | 0.790 |
Why?
|
Acetylation | 16 | 2020 | 1085 | 0.780 |
Why?
|
GTPase-Activating Proteins | 2 | 2022 | 498 | 0.770 |
Why?
|
Glutamates | 1 | 2021 | 398 | 0.720 |
Why?
|
High-Throughput Screening Assays | 3 | 2017 | 944 | 0.720 |
Why?
|
Cell Culture Techniques | 3 | 2016 | 1678 | 0.720 |
Why?
|
Biphenyl Compounds | 2 | 2016 | 913 | 0.700 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2019 | 514 | 0.700 |
Why?
|
Mental Disorders | 6 | 2016 | 6600 | 0.690 |
Why?
|
Cytoskeletal Proteins | 4 | 2021 | 1364 | 0.660 |
Why?
|
Glycogen Synthase Kinase 3 | 7 | 2018 | 430 | 0.650 |
Why?
|
Intercellular Signaling Peptides and Proteins | 6 | 2018 | 1676 | 0.630 |
Why?
|
Lysine | 5 | 2017 | 1007 | 0.630 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3462 | 0.620 |
Why?
|
MicroRNAs | 8 | 2023 | 3752 | 0.600 |
Why?
|
Enzyme Inhibitors | 11 | 2023 | 3798 | 0.600 |
Why?
|
Histone Deacetylase 2 | 9 | 2020 | 74 | 0.580 |
Why?
|
Memory | 4 | 2020 | 2174 | 0.580 |
Why?
|
Autophagy | 5 | 2021 | 1300 | 0.570 |
Why?
|
Trinucleotide Repeat Expansion | 2 | 2015 | 243 | 0.550 |
Why?
|
Cell Line | 20 | 2021 | 15997 | 0.540 |
Why?
|
Phosphorylation | 16 | 2023 | 8436 | 0.540 |
Why?
|
p21-Activated Kinases | 1 | 2016 | 128 | 0.540 |
Why?
|
Haloperidol | 1 | 2017 | 397 | 0.520 |
Why?
|
Cell Differentiation | 14 | 2022 | 11483 | 0.520 |
Why?
|
Mood Disorders | 2 | 2013 | 1106 | 0.510 |
Why?
|
Stress, Physiological | 2 | 2020 | 1403 | 0.510 |
Why?
|
Neuroglia | 1 | 2020 | 927 | 0.510 |
Why?
|
Schizophrenia | 8 | 2022 | 6882 | 0.510 |
Why?
|
Brain | 22 | 2022 | 26385 | 0.490 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2016 | 670 | 0.480 |
Why?
|
Neurofibromin 2 | 3 | 2021 | 267 | 0.480 |
Why?
|
Data Display | 2 | 2005 | 182 | 0.470 |
Why?
|
Neuroprotective Agents | 2 | 2019 | 941 | 0.470 |
Why?
|
Lithium Compounds | 3 | 2020 | 225 | 0.470 |
Why?
|
Positron-Emission Tomography | 11 | 2021 | 6234 | 0.450 |
Why?
|
Protein Kinase Inhibitors | 6 | 2020 | 5535 | 0.440 |
Why?
|
Amidohydrolases | 2 | 2004 | 169 | 0.440 |
Why?
|
Cyclin-Dependent Kinase 5 | 3 | 2023 | 112 | 0.440 |
Why?
|
Animals | 77 | 2023 | 168757 | 0.440 |
Why?
|
Histones | 14 | 2017 | 2599 | 0.440 |
Why?
|
Antimanic Agents | 2 | 2020 | 522 | 0.430 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 875 | 0.430 |
Why?
|
Phobic Disorders | 1 | 2015 | 439 | 0.430 |
Why?
|
Neurosciences | 1 | 2017 | 348 | 0.420 |
Why?
|
RNA, Untranslated | 2 | 2015 | 453 | 0.420 |
Why?
|
Mice | 51 | 2023 | 81183 | 0.410 |
Why?
|
Proteomics | 5 | 2021 | 3638 | 0.390 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 3 | 2019 | 142 | 0.390 |
Why?
|
Nootropic Agents | 1 | 2012 | 160 | 0.390 |
Why?
|
Ketamine | 1 | 2017 | 500 | 0.390 |
Why?
|
Prosencephalon | 2 | 2012 | 303 | 0.380 |
Why?
|
Lithium Chloride | 1 | 2011 | 87 | 0.380 |
Why?
|
Drug Design | 4 | 2021 | 1076 | 0.370 |
Why?
|
Neuregulin-1 | 1 | 2011 | 142 | 0.370 |
Why?
|
Pyrimidines | 8 | 2021 | 2942 | 0.370 |
Why?
|
Cells, Cultured | 18 | 2019 | 19229 | 0.370 |
Why?
|
Lithium | 4 | 2020 | 601 | 0.370 |
Why?
|
Gene Expression Regulation | 17 | 2022 | 12072 | 0.370 |
Why?
|
Fragile X Syndrome | 1 | 2011 | 115 | 0.370 |
Why?
|
Receptors, CXCR4 | 1 | 2015 | 726 | 0.360 |
Why?
|
Analgesics | 1 | 2017 | 1040 | 0.360 |
Why?
|
Synapses | 7 | 2022 | 1728 | 0.340 |
Why?
|
Gene Expression | 6 | 2019 | 7799 | 0.340 |
Why?
|
beta Catenin | 5 | 2015 | 1059 | 0.340 |
Why?
|
Humans | 104 | 2023 | 744343 | 0.340 |
Why?
|
Meningeal Neoplasms | 4 | 2021 | 1241 | 0.340 |
Why?
|
Anilides | 3 | 2016 | 408 | 0.340 |
Why?
|
Combinatorial Chemistry Techniques | 4 | 2005 | 129 | 0.340 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2021 | 1114 | 0.330 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 635 | 0.320 |
Why?
|
Protein Processing, Post-Translational | 6 | 2017 | 1990 | 0.320 |
Why?
|
Nerve Growth Factors | 1 | 2011 | 574 | 0.320 |
Why?
|
Models, Neurological | 2 | 2013 | 1774 | 0.320 |
Why?
|
Nervous System | 1 | 2011 | 554 | 0.310 |
Why?
|
RNA, Messenger | 6 | 2023 | 13033 | 0.310 |
Why?
|
DNA Methylation | 4 | 2015 | 4286 | 0.300 |
Why?
|
Mutation | 14 | 2021 | 29786 | 0.290 |
Why?
|
Tubulin | 4 | 2003 | 695 | 0.290 |
Why?
|
Dioxanes | 2 | 2004 | 37 | 0.290 |
Why?
|
Brain Diseases | 1 | 2016 | 1563 | 0.280 |
Why?
|
Gene Expression Profiling | 10 | 2020 | 9438 | 0.280 |
Why?
|
Antipsychotic Agents | 3 | 2019 | 3057 | 0.280 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2021 | 8949 | 0.280 |
Why?
|
Executive Function | 1 | 2015 | 1364 | 0.270 |
Why?
|
Ankyrins | 3 | 2018 | 128 | 0.270 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1622 | 0.270 |
Why?
|
Structure-Activity Relationship | 5 | 2016 | 3129 | 0.270 |
Why?
|
Mice, Inbred C57BL | 21 | 2022 | 21827 | 0.270 |
Why?
|
Mathematical Computing | 1 | 2005 | 147 | 0.270 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2916 | 0.270 |
Why?
|
Molecular Structure | 9 | 2019 | 1899 | 0.260 |
Why?
|
Meningioma | 3 | 2021 | 1209 | 0.260 |
Why?
|
Protein Isoforms | 5 | 2017 | 1730 | 0.260 |
Why?
|
Signal Transduction | 18 | 2021 | 23403 | 0.260 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2018 | 1213 | 0.260 |
Why?
|
Benzamides | 8 | 2015 | 1379 | 0.260 |
Why?
|
Cysteine | 2 | 2022 | 874 | 0.250 |
Why?
|
Amphetamine | 2 | 2020 | 225 | 0.250 |
Why?
|
Glutamic Acid | 2 | 2021 | 1169 | 0.250 |
Why?
|
Small Molecule Libraries | 4 | 2021 | 720 | 0.250 |
Why?
|
Phenotype | 6 | 2023 | 16365 | 0.240 |
Why?
|
Corpus Striatum | 3 | 2020 | 1221 | 0.240 |
Why?
|
Chromatin | 4 | 2014 | 2934 | 0.240 |
Why?
|
Computational Biology | 3 | 2020 | 3521 | 0.240 |
Why?
|
Neurilemmoma | 2 | 2021 | 547 | 0.240 |
Why?
|
Cardiac Glycosides | 1 | 2023 | 30 | 0.240 |
Why?
|
Benzophenones | 2 | 2021 | 57 | 0.240 |
Why?
|
Stem Cells | 3 | 2016 | 3567 | 0.240 |
Why?
|
Chromatids | 1 | 2003 | 63 | 0.230 |
Why?
|
Behavior, Animal | 5 | 2014 | 1881 | 0.230 |
Why?
|
Neurogenesis | 5 | 2020 | 838 | 0.230 |
Why?
|
Pyridines | 5 | 2021 | 2825 | 0.230 |
Why?
|
Models, Chemical | 1 | 2005 | 626 | 0.220 |
Why?
|
Fibroblasts | 6 | 2019 | 4161 | 0.220 |
Why?
|
Pluripotent Stem Cells | 3 | 2018 | 795 | 0.210 |
Why?
|
Lysosomes | 4 | 2021 | 893 | 0.210 |
Why?
|
Molecular Chaperones | 3 | 2019 | 742 | 0.210 |
Why?
|
Reversal Learning | 1 | 2022 | 60 | 0.200 |
Why?
|
Prefrontal Cortex | 3 | 2022 | 2147 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-fos | 2 | 2022 | 575 | 0.200 |
Why?
|
Mitosis | 3 | 2003 | 1208 | 0.190 |
Why?
|
RNA Interference | 4 | 2018 | 2889 | 0.190 |
Why?
|
Spermatogenesis | 2 | 2019 | 262 | 0.190 |
Why?
|
Cell Death | 3 | 2021 | 1706 | 0.190 |
Why?
|
Peptides | 3 | 2023 | 4409 | 0.190 |
Why?
|
Disease Models, Animal | 14 | 2023 | 18029 | 0.190 |
Why?
|
Organophosphorus Compounds | 1 | 2021 | 215 | 0.180 |
Why?
|
Gene Knockdown Techniques | 6 | 2022 | 1655 | 0.180 |
Why?
|
Light | 2 | 2017 | 1374 | 0.180 |
Why?
|
Fluspirilene | 1 | 2019 | 3 | 0.180 |
Why?
|
Embryo, Mammalian | 3 | 2017 | 1701 | 0.180 |
Why?
|
Gene Regulatory Networks | 3 | 2018 | 1708 | 0.180 |
Why?
|
Cerebrum | 1 | 2021 | 137 | 0.180 |
Why?
|
Spermatogonia | 1 | 2019 | 29 | 0.180 |
Why?
|
Cell Cycle | 4 | 2008 | 2967 | 0.180 |
Why?
|
Nicardipine | 1 | 2019 | 60 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2019 | 2503 | 0.180 |
Why?
|
Molecular Probes | 1 | 2021 | 316 | 0.180 |
Why?
|
Oxidative Stress | 2 | 2021 | 3086 | 0.180 |
Why?
|
Huntington Disease | 2 | 2020 | 1124 | 0.170 |
Why?
|
Fear | 4 | 2018 | 1440 | 0.170 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2019 | 59 | 0.170 |
Why?
|
Azepines | 1 | 2021 | 336 | 0.170 |
Why?
|
Farnesyltranstransferase | 1 | 2019 | 76 | 0.170 |
Why?
|
Verapamil | 1 | 2019 | 244 | 0.170 |
Why?
|
DNA Glycosylases | 1 | 2020 | 128 | 0.170 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2020 | 107 | 0.170 |
Why?
|
Phagosomes | 1 | 2020 | 193 | 0.170 |
Why?
|
Neurites | 2 | 2011 | 388 | 0.170 |
Why?
|
Neuropharmacology | 1 | 2018 | 21 | 0.170 |
Why?
|
Oxazoles | 2 | 2019 | 189 | 0.170 |
Why?
|
Parkinson Disease | 2 | 2019 | 2775 | 0.170 |
Why?
|
Colchicine | 1 | 2000 | 243 | 0.170 |
Why?
|
Benzothiazoles | 1 | 2019 | 248 | 0.160 |
Why?
|
Wnt Proteins | 3 | 2018 | 721 | 0.160 |
Why?
|
Thiazepines | 1 | 2018 | 30 | 0.160 |
Why?
|
Receptors, Eph Family | 1 | 2018 | 44 | 0.160 |
Why?
|
Nucleus Accumbens | 3 | 2010 | 366 | 0.160 |
Why?
|
Models, Molecular | 7 | 2019 | 5456 | 0.160 |
Why?
|
Neurofibrillary Tangles | 1 | 2020 | 439 | 0.160 |
Why?
|
Methyl-CpG-Binding Protein 2 | 2 | 2017 | 191 | 0.160 |
Why?
|
Protein Kinases | 2 | 2021 | 1640 | 0.160 |
Why?
|
Hippocampus | 7 | 2018 | 3675 | 0.160 |
Why?
|
Body Patterning | 2 | 2021 | 626 | 0.150 |
Why?
|
DNA Damage | 3 | 2020 | 2432 | 0.150 |
Why?
|
Neurofibromatosis 2 | 2 | 2018 | 380 | 0.150 |
Why?
|
Cocaine | 3 | 2013 | 1007 | 0.150 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2021 | 2455 | 0.150 |
Why?
|
Saccharomyces cerevisiae | 3 | 2006 | 2752 | 0.140 |
Why?
|
Mice, Transgenic | 8 | 2023 | 9734 | 0.140 |
Why?
|
Neurodegenerative Diseases | 2 | 2018 | 1061 | 0.140 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2017 | 604 | 0.140 |
Why?
|
RNA Splicing | 1 | 2021 | 907 | 0.140 |
Why?
|
Disulfiram | 1 | 2016 | 57 | 0.140 |
Why?
|
Phosphotransferases | 1 | 2017 | 308 | 0.140 |
Why?
|
Rats, Wistar | 1 | 2020 | 1901 | 0.140 |
Why?
|
Cytoskeleton | 2 | 2020 | 1185 | 0.140 |
Why?
|
Rett Syndrome | 2 | 2017 | 165 | 0.140 |
Why?
|
Microtubules | 5 | 2018 | 1090 | 0.140 |
Why?
|
Promoter Regions, Genetic | 7 | 2020 | 5867 | 0.140 |
Why?
|
Cell Line, Tumor | 11 | 2021 | 16689 | 0.140 |
Why?
|
Phenylenediamines | 2 | 2013 | 90 | 0.140 |
Why?
|
Oligodendroglia | 1 | 2019 | 517 | 0.140 |
Why?
|
Affect | 2 | 2014 | 1476 | 0.140 |
Why?
|
Autoradiography | 2 | 2014 | 745 | 0.130 |
Why?
|
Protein Stability | 1 | 2017 | 557 | 0.130 |
Why?
|
Mice, Knockout | 6 | 2022 | 14557 | 0.130 |
Why?
|
Membrane Glycoproteins | 3 | 2019 | 3768 | 0.130 |
Why?
|
Transcription Factors | 5 | 2021 | 12208 | 0.130 |
Why?
|
Haploinsufficiency | 1 | 2017 | 328 | 0.130 |
Why?
|
Organoids | 1 | 2021 | 701 | 0.130 |
Why?
|
Multigene Family | 1 | 2018 | 1102 | 0.130 |
Why?
|
Hydrogen Peroxide | 2 | 2016 | 731 | 0.130 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2018 | 895 | 0.130 |
Why?
|
Adamantane | 1 | 2016 | 173 | 0.130 |
Why?
|
Amino Acid Motifs | 1 | 2017 | 936 | 0.130 |
Why?
|
Cognition | 3 | 2022 | 6770 | 0.130 |
Why?
|
Sulfhydryl Compounds | 1 | 2016 | 298 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 315 | 0.130 |
Why?
|
Inhibitory Concentration 50 | 1 | 2016 | 459 | 0.130 |
Why?
|
Software | 4 | 2014 | 4443 | 0.130 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2015 | 125 | 0.130 |
Why?
|
Clenbuterol | 1 | 2014 | 9 | 0.130 |
Why?
|
Half-Life | 1 | 2016 | 661 | 0.120 |
Why?
|
HEK293 Cells | 3 | 2023 | 4204 | 0.120 |
Why?
|
Codon | 1 | 2016 | 611 | 0.120 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 503 | 0.120 |
Why?
|
Disulfides | 1 | 2016 | 457 | 0.120 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 449 | 0.120 |
Why?
|
Triazoles | 2 | 2019 | 911 | 0.120 |
Why?
|
Cell Survival | 3 | 2020 | 5882 | 0.120 |
Why?
|
Male | 30 | 2022 | 350118 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8428 | 0.120 |
Why?
|
Calcium Channels | 2 | 2015 | 622 | 0.120 |
Why?
|
Nerve Regeneration | 2 | 2010 | 788 | 0.120 |
Why?
|
Up-Regulation | 3 | 2021 | 4217 | 0.120 |
Why?
|
Lithium Carbonate | 1 | 2014 | 184 | 0.120 |
Why?
|
Radiopharmaceuticals | 3 | 2019 | 2645 | 0.120 |
Why?
|
Alzheimer Disease | 5 | 2020 | 8037 | 0.120 |
Why?
|
Aminopeptidases | 1 | 2013 | 88 | 0.120 |
Why?
|
Serine Proteases | 1 | 2013 | 52 | 0.110 |
Why?
|
Memory Disorders | 2 | 2012 | 1184 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2020 | 1783 | 0.110 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2013 | 88 | 0.110 |
Why?
|
Memory, Long-Term | 1 | 2014 | 64 | 0.110 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2014 | 202 | 0.110 |
Why?
|
Heterozygote | 2 | 2017 | 2804 | 0.110 |
Why?
|
Piperazines | 1 | 2003 | 2488 | 0.110 |
Why?
|
Research | 2 | 2011 | 1999 | 0.110 |
Why?
|
Gastrula | 1 | 2013 | 84 | 0.110 |
Why?
|
Rats | 7 | 2014 | 24260 | 0.110 |
Why?
|
Tritium | 1 | 2013 | 745 | 0.110 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2013 | 113 | 0.110 |
Why?
|
Paclitaxel | 1 | 2000 | 1708 | 0.110 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2016 | 581 | 0.110 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 453 | 0.110 |
Why?
|
Indoles | 2 | 2017 | 1839 | 0.110 |
Why?
|
Kinetics | 5 | 2020 | 6473 | 0.110 |
Why?
|
Blood-Brain Barrier | 2 | 2019 | 1017 | 0.100 |
Why?
|
Cell Proliferation | 6 | 2021 | 10481 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2020 | 2109 | 0.100 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2014 | 3617 | 0.100 |
Why?
|
Indole Alkaloids | 1 | 2011 | 24 | 0.100 |
Why?
|
Synaptic Transmission | 1 | 2018 | 1178 | 0.100 |
Why?
|
Tuberous Sclerosis | 1 | 2020 | 1029 | 0.100 |
Why?
|
Amino Acid Substitution | 1 | 2016 | 1791 | 0.100 |
Why?
|
Membrane Potentials | 1 | 2015 | 1137 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2915 | 0.100 |
Why?
|
Biological Assay | 2 | 2019 | 652 | 0.100 |
Why?
|
Central Nervous System | 1 | 2019 | 1357 | 0.100 |
Why?
|
Transcription, Genetic | 5 | 2018 | 7722 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2016 | 1285 | 0.100 |
Why?
|
Nuclear Proteins | 2 | 2020 | 5853 | 0.100 |
Why?
|
PC12 Cells | 1 | 2011 | 330 | 0.100 |
Why?
|
Morpholines | 3 | 2021 | 571 | 0.100 |
Why?
|
Genes, Reporter | 2 | 2012 | 1547 | 0.100 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 188 | 0.100 |
Why?
|
Drug Administration Routes | 1 | 2011 | 153 | 0.100 |
Why?
|
Recombinant Proteins | 3 | 2014 | 6622 | 0.100 |
Why?
|
Pyrroles | 1 | 2017 | 1146 | 0.100 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 1414 | 0.100 |
Why?
|
Carbon Radioisotopes | 3 | 2019 | 577 | 0.100 |
Why?
|
Riluzole | 1 | 2010 | 55 | 0.090 |
Why?
|
Principal Component Analysis | 2 | 2004 | 940 | 0.090 |
Why?
|
Macrocyclic Compounds | 1 | 2010 | 72 | 0.090 |
Why?
|
CpG Islands | 2 | 2012 | 1172 | 0.090 |
Why?
|
Zebrafish Proteins | 2 | 2014 | 1005 | 0.090 |
Why?
|
Capillary Permeability | 1 | 2014 | 798 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 376 | 0.090 |
Why?
|
Anticonvulsants | 1 | 2020 | 1916 | 0.090 |
Why?
|
Sirolimus | 5 | 2020 | 1564 | 0.090 |
Why?
|
HeLa Cells | 1 | 2016 | 3128 | 0.090 |
Why?
|
Single-Cell Analysis | 2 | 2019 | 2183 | 0.090 |
Why?
|
Protein Binding | 4 | 2016 | 9386 | 0.090 |
Why?
|
Mice, Inbred DBA | 1 | 2011 | 642 | 0.090 |
Why?
|
Family Health | 1 | 2015 | 1282 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1940 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 1526 | 0.090 |
Why?
|
Carbazoles | 1 | 2011 | 226 | 0.090 |
Why?
|
Aldehydes | 1 | 2010 | 167 | 0.090 |
Why?
|
Electrical Synapses | 1 | 2009 | 19 | 0.090 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 898 | 0.090 |
Why?
|
Dendrites | 1 | 2012 | 485 | 0.090 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2014 | 615 | 0.090 |
Why?
|
DNA Copy Number Variations | 2 | 2015 | 1941 | 0.090 |
Why?
|
Animals, Newborn | 2 | 2012 | 2726 | 0.090 |
Why?
|
Xenopus laevis | 1 | 2013 | 957 | 0.080 |
Why?
|
Mosaicism | 1 | 2011 | 441 | 0.080 |
Why?
|
Mitochondria | 1 | 2021 | 3520 | 0.080 |
Why?
|
Phosphoproteins | 2 | 2016 | 2440 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1240 | 0.080 |
Why?
|
Protein Array Analysis | 2 | 2007 | 411 | 0.080 |
Why?
|
Repressor Proteins | 2 | 2009 | 3023 | 0.080 |
Why?
|
Methylation | 3 | 2020 | 1106 | 0.080 |
Why?
|
Tacrolimus Binding Protein 1A | 1 | 2007 | 39 | 0.080 |
Why?
|
Cocaine-Related Disorders | 2 | 2010 | 460 | 0.080 |
Why?
|
Antineoplastic Agents | 4 | 2018 | 13695 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2016 | 15519 | 0.080 |
Why?
|
Female | 20 | 2021 | 380194 | 0.080 |
Why?
|
Analysis of Variance | 3 | 2011 | 6365 | 0.080 |
Why?
|
Streptomyces | 1 | 2007 | 89 | 0.070 |
Why?
|
Melanoma, Experimental | 1 | 2010 | 561 | 0.070 |
Why?
|
Synaptophysin | 2 | 2017 | 141 | 0.070 |
Why?
|
Genomics | 3 | 2011 | 5720 | 0.070 |
Why?
|
Zebrafish | 3 | 2018 | 2994 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3589 | 0.070 |
Why?
|
Multifactorial Inheritance | 1 | 2014 | 1194 | 0.070 |
Why?
|
Biological Factors | 1 | 2007 | 164 | 0.070 |
Why?
|
Cadherins | 1 | 2011 | 907 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 2015 | 0.070 |
Why?
|
Drug Interactions | 1 | 2011 | 1460 | 0.070 |
Why?
|
Cell Nucleus | 3 | 2020 | 2969 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2013 | 828 | 0.070 |
Why?
|
Testis | 2 | 2019 | 803 | 0.070 |
Why?
|
Immunoblotting | 3 | 2015 | 1682 | 0.070 |
Why?
|
Transfection | 2 | 2011 | 5892 | 0.070 |
Why?
|
Calcium | 2 | 2017 | 5756 | 0.070 |
Why?
|
Microscopy | 1 | 2010 | 903 | 0.070 |
Why?
|
Amino Acid Sequence | 2 | 2021 | 13815 | 0.060 |
Why?
|
GTP-Binding Proteins | 2 | 2019 | 970 | 0.060 |
Why?
|
Jurkat Cells | 2 | 2004 | 743 | 0.060 |
Why?
|
Cell Membrane | 1 | 2015 | 3748 | 0.060 |
Why?
|
Sequence Analysis, RNA | 3 | 2018 | 2012 | 0.060 |
Why?
|
Dementia | 1 | 2018 | 2518 | 0.060 |
Why?
|
Molecular Conformation | 2 | 2019 | 563 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 17446 | 0.060 |
Why?
|
Diketopiperazines | 1 | 2003 | 20 | 0.060 |
Why?
|
Time Factors | 4 | 2020 | 40075 | 0.060 |
Why?
|
Nerve Degeneration | 1 | 2008 | 748 | 0.060 |
Why?
|
Pyrones | 1 | 2003 | 36 | 0.060 |
Why?
|
Developmental Disabilities | 1 | 2012 | 1456 | 0.060 |
Why?
|
Cyclin B1 | 1 | 2003 | 52 | 0.060 |
Why?
|
Psychotropic Drugs | 1 | 2010 | 894 | 0.060 |
Why?
|
Motor Activity | 2 | 2014 | 2714 | 0.060 |
Why?
|
Cyclin B | 1 | 2003 | 108 | 0.060 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2003 | 87 | 0.060 |
Why?
|
Genes, cdc | 1 | 2003 | 116 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2018 | 19905 | 0.060 |
Why?
|
Aminophenols | 1 | 2003 | 78 | 0.060 |
Why?
|
Genetic Techniques | 2 | 2003 | 435 | 0.060 |
Why?
|
Caenorhabditis elegans | 2 | 2010 | 1419 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2013 | 2072 | 0.060 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2003 | 121 | 0.060 |
Why?
|
Crystallography, X-Ray | 2 | 2019 | 2011 | 0.060 |
Why?
|
Larva | 2 | 2018 | 519 | 0.060 |
Why?
|
Brain Mapping | 1 | 2018 | 6669 | 0.060 |
Why?
|
Wakefulness | 1 | 2010 | 1245 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4933 | 0.050 |
Why?
|
RNA, Small Interfering | 3 | 2019 | 3505 | 0.050 |
Why?
|
Cytokines | 2 | 2015 | 7322 | 0.050 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 3846 | 0.050 |
Why?
|
Tissue Donors | 1 | 2011 | 2240 | 0.050 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2009 | 828 | 0.050 |
Why?
|
Middle Aged | 6 | 2021 | 213383 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2012 | 2585 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 18111 | 0.050 |
Why?
|
Antidepressive Agents | 2 | 2014 | 2838 | 0.050 |
Why?
|
Ubiquitination | 2 | 2017 | 1012 | 0.050 |
Why?
|
Benzazepines | 1 | 2003 | 326 | 0.050 |
Why?
|
3T3 Cells | 1 | 2003 | 1101 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2018 | 21746 | 0.050 |
Why?
|
Computer Graphics | 1 | 2003 | 361 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8664 | 0.050 |
Why?
|
Glucose | 1 | 2013 | 4397 | 0.050 |
Why?
|
Hydrazones | 1 | 2021 | 102 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2022 | 317 | 0.050 |
Why?
|
Genetic Variation | 1 | 2016 | 6544 | 0.050 |
Why?
|
Recombination, Genetic | 1 | 2006 | 1586 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2012 | 3920 | 0.050 |
Why?
|
Databases, Factual | 2 | 2006 | 7729 | 0.050 |
Why?
|
Radiochemistry | 1 | 2020 | 55 | 0.050 |
Why?
|
Blood-Testis Barrier | 1 | 2019 | 11 | 0.050 |
Why?
|
Thiones | 1 | 1999 | 46 | 0.040 |
Why?
|
Radioactive Tracers | 1 | 2020 | 72 | 0.040 |
Why?
|
Automation | 2 | 2014 | 584 | 0.040 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2017 | 1338 | 0.040 |
Why?
|
Risk Factors | 3 | 2015 | 72290 | 0.040 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6314 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 1 | 2003 | 2505 | 0.040 |
Why?
|
Pentylenetetrazole | 1 | 2018 | 69 | 0.040 |
Why?
|
Microscopy, Fluorescence | 2 | 2011 | 2699 | 0.040 |
Why?
|
Guanine | 1 | 2020 | 274 | 0.040 |
Why?
|
Convulsants | 1 | 2018 | 70 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 3772 | 0.040 |
Why?
|
G2 Phase | 1 | 1998 | 139 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2020 | 281 | 0.040 |
Why?
|
Isotope Labeling | 1 | 2020 | 406 | 0.040 |
Why?
|
Down-Regulation | 2 | 2020 | 3002 | 0.040 |
Why?
|
Macaca | 1 | 2019 | 440 | 0.040 |
Why?
|
Blotting, Western | 3 | 2013 | 5179 | 0.040 |
Why?
|
Fetus | 2 | 2018 | 1880 | 0.040 |
Why?
|
Quantitative Trait Loci | 1 | 2006 | 2019 | 0.040 |
Why?
|
Dendritic Spines | 2 | 2010 | 233 | 0.040 |
Why?
|
Protein Transport | 1 | 2003 | 1988 | 0.040 |
Why?
|
Mossy Fibers, Hippocampal | 1 | 2017 | 30 | 0.040 |
Why?
|
Smad Proteins | 1 | 2018 | 162 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2003 | 1086 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2023 | 1072 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2023 | 3597 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 173 | 0.040 |
Why?
|
Epigenomics | 2 | 2014 | 903 | 0.040 |
Why?
|
CA3 Region, Hippocampal | 1 | 2017 | 56 | 0.040 |
Why?
|
Receptors, Glutamate | 1 | 2018 | 232 | 0.040 |
Why?
|
DNA Primers | 2 | 2013 | 2892 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2019 | 698 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10943 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9648 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2019 | 229 | 0.040 |
Why?
|
Amination | 1 | 2016 | 19 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2022 | 2187 | 0.040 |
Why?
|
Chromosomes | 1 | 2000 | 596 | 0.040 |
Why?
|
Xenopus Proteins | 1 | 1999 | 433 | 0.040 |
Why?
|
Peer Review, Research | 1 | 2000 | 329 | 0.040 |
Why?
|
Golgi Apparatus | 2 | 2013 | 410 | 0.040 |
Why?
|
Adult | 6 | 2020 | 214055 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2018 | 513 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1998 | 358 | 0.040 |
Why?
|
Pyridazines | 1 | 2018 | 202 | 0.040 |
Why?
|
Thiazoles | 1 | 2003 | 1483 | 0.030 |
Why?
|
Receptors, AMPA | 1 | 2018 | 331 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2000 | 780 | 0.030 |
Why?
|
Azo Compounds | 1 | 2016 | 113 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2023 | 5097 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2017 | 293 | 0.030 |
Why?
|
Binding Sites | 2 | 2015 | 6114 | 0.030 |
Why?
|
Isoenzymes | 2 | 2015 | 1726 | 0.030 |
Why?
|
Gene Deletion | 1 | 2003 | 2751 | 0.030 |
Why?
|
Base Sequence | 2 | 2020 | 12797 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2013 | 5181 | 0.030 |
Why?
|
Algorithms | 3 | 2020 | 13881 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2004 | 1888 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2014 | 2715 | 0.030 |
Why?
|
Staurosporine | 2 | 2010 | 251 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8301 | 0.030 |
Why?
|
Sodium-Bicarbonate Symporters | 1 | 2014 | 32 | 0.030 |
Why?
|
Papio anubis | 1 | 2014 | 25 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 469 | 0.030 |
Why?
|
Axons | 2 | 2014 | 1684 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 625 | 0.030 |
Why?
|
Myocardium | 2 | 2014 | 4776 | 0.030 |
Why?
|
Gemfibrozil | 1 | 2013 | 30 | 0.030 |
Why?
|
DNA | 2 | 2022 | 7301 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1878 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2018 | 1549 | 0.030 |
Why?
|
Lymphocytes | 2 | 2012 | 2617 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2017 | 5172 | 0.030 |
Why?
|
Fenofibrate | 1 | 2013 | 88 | 0.030 |
Why?
|
Brain Chemistry | 1 | 2017 | 981 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2003 | 2716 | 0.030 |
Why?
|
Quinolines | 1 | 2018 | 732 | 0.030 |
Why?
|
Yolk Sac | 1 | 2013 | 75 | 0.030 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2014 | 281 | 0.030 |
Why?
|
Papio | 1 | 2014 | 656 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2012 | 98 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
Cytoplasm | 1 | 2017 | 1539 | 0.030 |
Why?
|
Drug Evaluation | 1 | 2014 | 647 | 0.030 |
Why?
|
Organ Specificity | 1 | 2017 | 2008 | 0.030 |
Why?
|
Gene Order | 1 | 2012 | 176 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2000 | 1504 | 0.030 |
Why?
|
Astrocytes | 1 | 2020 | 1270 | 0.030 |
Why?
|
Publishing | 1 | 2000 | 833 | 0.030 |
Why?
|
Imidazoles | 1 | 1998 | 1206 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2007 | 4245 | 0.030 |
Why?
|
Ubiquitin | 1 | 2017 | 852 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2006 | 434 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 2013 | 218 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2019 | 1836 | 0.030 |
Why?
|
Reward | 2 | 2010 | 941 | 0.030 |
Why?
|
Young Adult | 2 | 2016 | 56430 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1788 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2013 | 1157 | 0.030 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2012 | 326 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2015 | 1246 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2012 | 417 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2011 | 25625 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2017 | 3701 | 0.020 |
Why?
|
Proteins | 2 | 2004 | 6103 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2014 | 1866 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2012 | 296 | 0.020 |
Why?
|
Piperidines | 1 | 2019 | 1602 | 0.020 |
Why?
|
Electrophysiology | 1 | 2013 | 1308 | 0.020 |
Why?
|
Neoplasms | 3 | 2017 | 21683 | 0.020 |
Why?
|
Enzyme Repression | 1 | 2010 | 32 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1799 | 0.020 |
Why?
|
Models, Genetic | 1 | 2020 | 3494 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
X Chromosome Inactivation | 1 | 2012 | 224 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2014 | 675 | 0.020 |
Why?
|
Receptors, Glucocorticoid | 1 | 2012 | 302 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2010 | 70 | 0.020 |
Why?
|
Valproic Acid | 1 | 2013 | 445 | 0.020 |
Why?
|
Genome-Wide Association Study | 3 | 2014 | 12261 | 0.020 |
Why?
|
Dominance-Subordination | 1 | 2009 | 27 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2019 | 2866 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 624 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 418 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2011 | 440 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2009 | 126 | 0.020 |
Why?
|
Adolescent | 2 | 2015 | 85781 | 0.020 |
Why?
|
Potassium Channel Blockers | 1 | 2010 | 171 | 0.020 |
Why?
|
DNA Repair | 1 | 1998 | 2046 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 2017 | 1071 | 0.020 |
Why?
|
Caspase 3 | 1 | 2011 | 758 | 0.020 |
Why?
|
Comet Assay | 1 | 2008 | 71 | 0.020 |
Why?
|
Fluorescence | 1 | 2011 | 751 | 0.020 |
Why?
|
DNA Helicases | 1 | 2014 | 859 | 0.020 |
Why?
|
New York | 1 | 2011 | 886 | 0.020 |
Why?
|
Apoptosis | 2 | 2018 | 9727 | 0.020 |
Why?
|
Data Mining | 1 | 2014 | 537 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2018 | 3420 | 0.020 |
Why?
|
Sucrose | 1 | 2009 | 164 | 0.020 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2010 | 211 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 41006 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2011 | 730 | 0.020 |
Why?
|
Self Administration | 1 | 2010 | 385 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2013 | 1950 | 0.020 |
Why?
|
Nerve Tissue | 1 | 2008 | 79 | 0.020 |
Why?
|
Skin Pigmentation | 1 | 2010 | 282 | 0.020 |
Why?
|
Sulfonamides | 1 | 2018 | 1938 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1620 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1801 | 0.020 |
Why?
|
Butyrates | 1 | 2009 | 163 | 0.020 |
Why?
|
Calcium Channels, L-Type | 1 | 2010 | 240 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2429 | 0.020 |
Why?
|
Africa | 1 | 2010 | 673 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2009 | 549 | 0.020 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2008 | 285 | 0.020 |
Why?
|
RNA Polymerase II | 1 | 2012 | 551 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2011 | 1341 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2013 | 1144 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11366 | 0.020 |
Why?
|
Internet | 1 | 2000 | 3064 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2012 | 1117 | 0.020 |
Why?
|
Drug Synergism | 1 | 2011 | 1792 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1420 | 0.020 |
Why?
|
Limonins | 1 | 2006 | 24 | 0.020 |
Why?
|
Conditioning, Classical | 1 | 2009 | 366 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2009 | 216 | 0.020 |
Why?
|
Phenothiazines | 1 | 2006 | 63 | 0.020 |
Why?
|
Sweetening Agents | 1 | 2009 | 296 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2000 | 4665 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2010 | 690 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2008 | 644 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2010 | 1801 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2437 | 0.020 |
Why?
|
Presenilin-1 | 1 | 2009 | 635 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2009 | 868 | 0.020 |
Why?
|
Ligands | 1 | 2013 | 3282 | 0.020 |
Why?
|
Genome | 1 | 2014 | 1808 | 0.020 |
Why?
|
Seizures | 1 | 2018 | 2859 | 0.020 |
Why?
|
Food Preferences | 1 | 2009 | 399 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2008 | 893 | 0.020 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2007 | 312 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4568 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6171 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2010 | 1227 | 0.020 |
Why?
|
Adenine | 1 | 2011 | 936 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2020 | 4043 | 0.020 |
Why?
|
Fluoxetine | 1 | 2009 | 749 | 0.020 |
Why?
|
Cisplatin | 1 | 2011 | 1662 | 0.020 |
Why?
|
Microfluidics | 1 | 2010 | 662 | 0.020 |
Why?
|
Microsurgery | 1 | 2010 | 796 | 0.020 |
Why?
|
Rest | 1 | 2010 | 901 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2025 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 2016 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2012 | 1294 | 0.020 |
Why?
|
Autistic Disorder | 1 | 2014 | 1185 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 3144 | 0.010 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2008 | 594 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1741 | 0.010 |
Why?
|
Quinones | 1 | 2004 | 76 | 0.010 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2009 | 1121 | 0.010 |
Why?
|
Cyclooxygenase 1 | 1 | 2004 | 104 | 0.010 |
Why?
|
Psychotic Disorders | 1 | 2018 | 3046 | 0.010 |
Why?
|
Sodium | 1 | 2009 | 1623 | 0.010 |
Why?
|
Laser Therapy | 1 | 2010 | 1072 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.010 |
Why?
|
Benzoquinones | 1 | 2004 | 201 | 0.010 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2006 | 502 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2088 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 329 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2014 | 7880 | 0.010 |
Why?
|
Lactams, Macrocyclic | 1 | 2004 | 320 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2009 | 1425 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2004 | 371 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2203 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2004 | 320 | 0.010 |
Why?
|
Biological Products | 1 | 2010 | 860 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2014 | 3748 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10180 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2004 | 611 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6933 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1312 | 0.010 |
Why?
|
Oxygen | 1 | 2012 | 4189 | 0.010 |
Why?
|
Equipment Design | 1 | 2009 | 3582 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1790 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2727 | 0.010 |
Why?
|
Ischemia | 1 | 2008 | 1907 | 0.010 |
Why?
|
Cell Movement | 1 | 2012 | 5217 | 0.010 |
Why?
|
Biosensing Techniques | 1 | 2006 | 668 | 0.010 |
Why?
|
Mink | 1 | 1999 | 44 | 0.010 |
Why?
|
Learning | 1 | 2009 | 1713 | 0.010 |
Why?
|
Molecular Motor Proteins | 1 | 1999 | 107 | 0.010 |
Why?
|
Estrogens | 1 | 2006 | 1566 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2010 | 2002 | 0.010 |
Why?
|
Porifera | 1 | 1999 | 33 | 0.010 |
Why?
|
Dexamethasone | 1 | 2006 | 1951 | 0.010 |
Why?
|
Succinimides | 1 | 1998 | 79 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4420 | 0.010 |
Why?
|
Amyloid beta-Peptides | 1 | 2012 | 3587 | 0.010 |
Why?
|
Kidney | 1 | 2014 | 7186 | 0.010 |
Why?
|
Antimetabolites | 1 | 1999 | 125 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 1999 | 322 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2010 | 3690 | 0.010 |
Why?
|
Xenopus | 1 | 1999 | 712 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 1519 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4740 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57776 | 0.010 |
Why?
|
Genes, p53 | 1 | 1998 | 755 | 0.010 |
Why?
|
Emotions | 1 | 2007 | 2661 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 5987 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4838 | 0.010 |
Why?
|
Sleep | 1 | 2010 | 4623 | 0.010 |
Why?
|
Cattle | 1 | 1999 | 3922 | 0.010 |
Why?
|
Chronic Disease | 1 | 2007 | 9146 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2008 | 5708 | 0.010 |
Why?
|
United States | 1 | 2000 | 69872 | 0.010 |
Why?
|
Actins | 1 | 1999 | 2121 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3870 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1999 | 2126 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 1999 | 1903 | 0.010 |
Why?
|
Depression | 1 | 2009 | 7766 | 0.010 |
Why?
|
Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
Infant | 1 | 2010 | 35136 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2014 | 63114 | 0.000 |
Why?
|
Obesity | 1 | 2006 | 12745 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1998 | 6364 | 0.000 |
Why?
|
Lung | 1 | 1999 | 9856 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1998 | 13102 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1998 | 20822 | 0.000 |
Why?
|